Safety of Bronchial Thermoplasty Performed With the Alair® System During Two Treatment Sessions to Treat Severe Asthma
NCT00803088 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2021-02-01
Summary
The objective of this multicenter, single-arm, open-label clinical study is to evaluate the safety of performing bronchial thermoplasty with the Alair® System during two treatment sessions to treat severe asthma.
Conditions
Interventions
- DEVICE
-
The Alair System
Treatment of airways with the Alair System
Sponsors & Collaborators
-
Boston Scientific Corporation
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Bronchial Thermoplasty in Severe Asthma With Frequent Exacerbations
NCT02464995 ·Status: UNKNOWN ·Phase: NA
-
Unravelling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma
NCT02225392 ·Status: COMPLETED ·Phase: NA
-
Research in Severe Asthma (RISA) Trial
NCT00214539 ·Status: COMPLETED ·Phase: NA
-
China Alair System Registry Study-CARE Study
NCT02206269 ·Status: UNKNOWN
-
Bicentric Prospective Study, Evaluating Bronchial THERMOPLASTY in a Patient Presenting Severe Uncontrolled Asthma
NCT01777360 ·Status: UNKNOWN ·Phase: PHASE3
-
Asthma Intervention Research 2 (AIR2) Trial
NCT00231114 ·Status: COMPLETED ·Phase: NA
-
A Prospective Observational Study of Biopredictors of Bronchial Thermoplasty Response in Patients With Severe Refractory Asthma (BTR Study)
NCT01185275 ·Status: COMPLETED
-
Effectiveness of the Aeroneb in Acute Severe Asthma
NCT03029156 ·Status: COMPLETED ·Phase: NA
-
Bronchial Thermoplasty Global Registry
NCT02104856 ·Status: COMPLETED
-
A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing
NCT01218009 ·Status: TERMINATED ·Phase: PHASE3
-
Effectiveness and Cost Study Comparing Two Ways to Deliver Albuterol for the Treatment of Asthma in the Hospital
NCT00623688 ·Status: COMPLETED ·Phase: NA
-
An Observational Prospective Study to Characterize Patients Initiating Enerzair® Breezhaler®, With or Without Sensor, as a Maintenance Treatment for Asthma
NCT05120986 ·Status: WITHDRAWN
-
Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma
NCT02241265 ·Status: RECRUITING
-
Allergy Immunotherapy for the Reduction of Asthma
NCT01028560 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bronchial Thermoplasty: Effect on Neuronal and Chemosensitive Component of the Bronchial Mucosa
NCT01839591 ·Status: COMPLETED ·Phase: NA
-
A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL
NCT00801853 ·Status: COMPLETED ·Phase: PHASE2
-
Individualized Therapy For Asthma in Toddlers
NCT01606306 ·Status: COMPLETED ·Phase: PHASE3
-
Bronchial Ablation for Treatment of Asthma (BATA) Trial
NCT03765307 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
NCT01462344 ·Status: COMPLETED ·Phase: PHASE4
-
A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma
NCT00109200 ·Status: COMPLETED ·Phase: PHASE3
-
An Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143g
NCT00109187 ·Status: COMPLETED ·Phase: PHASE3
-
Alendronate to Prevent Loss of Bronchoprotection in Asthma
NCT02230332 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)
NCT02720081 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Physiopathological Mechanisms and Results of Treatment With Bronchial Thermoplasty in Severe Asthma
NCT01974921 ·Status: UNKNOWN ·Phase: NA
-
Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids
NCT00353873 ·Status: COMPLETED ·Phase: PHASE4